From 1 April 2003 Experts from the 10 first wave accession countries will participate as observers in the Scientific Committees and working parties of the European Agency for the Evaluation of Medicinal Products (EMEA). This builds on a preparatory training and exchange programme run between EMEA and the CEE countries financed through the EU Phare programme.
putting citizens' health at the heart of Europe
Enlargement Countries Join EMEA Board
Last modified on May 6 2003.
Your feedback is valuable to us!
Was this article interesting and relevant
for you? Do you have any comments?
You can post a reply to this article here.
Credits
The European Public Health Alliance runs projects which receive financial support from the European Commission. The views expressed in this website do not necessarily reflect the official views of the EU institutions.
This website is powered by open source solutions and runs on a Linux server.